Your browser doesn't support javascript.
loading
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma.
Ruggiero, Ciro Francesco; Fattore, Luigi; Terrenato, Irene; Sperati, Francesca; Salvati, Valentina; Madonna, Gabriele; Capone, Mariaelena; Valenti, Fabio; Di Martino, Simona; Mandoj, Chiara; Liguoro, Domenico; Castaldo, Vittorio; Cafaro, Giordana; Simeone, Ester; Vanella, Vito; Russillo, Michelangelo; Conti, Laura; Cuda, Giovanni; Giannarelli, Diana; Ascierto, Paolo Antonio; Mancini, Rita; Ciliberto, Gennaro.
  • Ruggiero CF; Department of Melanoma, Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, Italy.
  • Fattore L; SAFU Laboratory, Department of Research, Advanced Diagnostics and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Terrenato I; UOSD Clinical Trial Center e Biostatistica e Bioinformatica, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Sperati F; UOSD Clinical Trial Center e Biostatistica e Bioinformatica, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Salvati V; Department. Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Madonna G; Department of Melanoma, Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, Italy.
  • Capone M; Department of Melanoma, Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, Italy.
  • Valenti F; Oncogenomic and Epigenetic Unit, Department of Diagnostic Research and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Di Martino S; Biological Tissue and Liquid Bank, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Mandoj C; Clinical Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Liguoro D; Department of Molecular and Clinical Medicine, University of Rome "Sapienza", 00161 Rome, Italy.
  • Castaldo V; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Cafaro G; Department. Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Simeone E; Department of Melanoma, Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, Italy.
  • Vanella V; Department of Melanoma, Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, Italy.
  • Russillo M; Division of Medical Oncology1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Conti L; Clinical Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Cuda G; Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Giannarelli D; UOSD Clinical Trial Center e Biostatistica e Bioinformatica, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, Italy.
  • Mancini R; Department of Molecular and Clinical Medicine, University of Rome "Sapienza", 00161 Rome, Italy.
  • Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Theranostics ; 12(17): 7420-7430, 2022.
Article en En | MEDLINE | ID: mdl-36438490
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / MicroARNs / MicroARN Circulante / Melanoma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / MicroARNs / MicroARN Circulante / Melanoma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article